TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
ADVISORY COMMITTEE
January 19, 2001
Slides
Chronic Wasting Disease, FDA/CFSAN Regulatory Issues, Robert E Brackett PhD, FDA
Elk Industry Perspective on Chronic Wasting Disease, Dr. Zebarth
Issue 4. Potential Exposure of Blood, Plasma & Tissue Donors to Various TSE Agents of Animals
Charge and Questions for Topic 4
Animal-Derived Dietary Supplement Ingredients, Robert J Moore, PhD, FDA
Comments of the Greater New York Hospital Association, Kenneth E Raske
Comments from Terry S Singletary Sr.
Statement of America's Blood Centers, Dr Merlyn Sayers, MD, PhD
Statement of Impact from the New York Blood Center, Dr Robert Jones
Tissue Banks International (TBI), Gerald J Cole
Comments from Joseph H Davis MD, Emeritus University of Miami
Testimony of Bess Believeaux, Lions Eye Bank of Central Texas
News Release, American Red Cross Urges Tightened Restructions on Blood Donors Who Resided in Europe
American Red Cross Position Statement to the Transmissible Spongiform Encephalopthy (TSE) Committee